share_log

CareCloud, Inc. Solicits Shareholder Approval for Increase in Authorized Shares to Support Growth Initiatives

CareCloud, Inc. Solicits Shareholder Approval for Increase in Authorized Shares to Support Growth Initiatives

CareCloud, Inc. 徵求股東批准增加授權股份以支持增長計劃
Quiver Quantitative ·  12/09 08:21

CareCloud seeks shareholder approval to increase authorized shares from 35 million to 85 million for growth initiatives.

CareCloud尋求股東批准將授權股份從3500萬增至8500萬,以支持增長計劃。

Quiver AI Summary

Quiver AI 概要

CareCloud, Inc. has announced its plan to solicit proxies from common stock shareholders to approve an increase in the authorized shares from 35 million to 85 million. This move aims to support the company's growth initiatives, including potential acquisitions and the conversion of outstanding preferred stock. Founder and Executive Chairman Mahmud Haq emphasized the importance of this proposal for driving sustained revenue and profitability. CareCloud has shown strong financial performance, achieving a 23% compound annual growth rate over the past decade, and generated over $10 million in free cash flow in the first three quarters of 2024. The special meeting for shareholders to vote on this proposal is scheduled for January 27, 2025, with various voting methods available.

CareCloud, Inc.宣佈計劃向普通股股東征求代理以批准將授權股份從3500萬增至8500萬。這一舉措旨在支持公司的增長計劃,包括潛在收購和轉換已發行的優先股。創始人兼執行主席Mahmud Haq強調了這一提案對推動持續營業收入和盈利能力的重要性。CareCloud表現出強勁的財務業績,在過去十年實現了23%的複合年增長率,並在2024年前三季度產生了超過1000萬的自由現金流。股東投票該提案的特別會議定於2025年1月27日舉行,提供多種投票方式。

Potential Positives

潛在的積極因素

  • The proposal to increase authorized shares from 35 million to 85 million indicates the company's commitment to support growth initiatives and enhance financial flexibility.
  • The reported 50% year-over-year increase in adjusted EBITDA showcases the company's strong financial performance and its ability to generate significant earnings.
  • CareCloud has achieved a 23% compound annual growth rate over the past decade, reflecting its successful growth strategy through both acquisitions and organic growth.
  • Over $10 million in free cash flow generated during the first three quarters of 2024 positions the company well for future investments and strategic maneuvers.
  • 將授權股份從3500萬增至8500萬的提案表明公司致力於支持增長計劃並增強財務靈活性。
  • 報告顯示調整後的EBITDA同比增長50%,展示了公司的強勁財務業績及其產生顯著盈利的能力。
  • CareCloud在過去十年中實現了23%的複合年增長率,反映了其通過收購和有機增長的成功增長策略。
  • 在2024年前三季度產生的超過1000萬的自由現金流爲公司未來的投資和戰略行動奠定了良好基礎。

Potential Negatives

潛在負面影響

  • The proposed increase in authorized shares from 35 million to 85 million may lead to shareholder dilution, which could negatively impact current shareholders' ownership percentage and value.
  • The need for a significant increase in authorized shares may signal potential challenges in financing growth through traditional means, raising concerns about the company's financial health and business strategies.
  • The reliance on acquisitions for growth and the expressed need for additional authorized shares could indicate that organic growth alone is insufficient, possibly undermining investor confidence in the company's independent growth potential.
  • 提議將授權股份從3500萬增加到8500萬可能會導致股東稀釋,這可能對當前股東的持股比例和價值產生負面影響。
  • 對授權股份顯著增加的需求可能表明通過傳統方式融資增長可能面臨潛在挑戰,這引發了對公司財務健康狀況和業務策略的擔憂。
  • 對收購增長的依賴以及對額外授權股份的表達需求可能表明單靠有機增長是不夠的,這可能削弱投資者對公司獨立增長潛力的信心。

FAQ

常見問題

What is the purpose of CareCloud's proxy solicitation?

CareCloud的代理徵集目的是什麼?

CareCloud is soliciting proxies to approve an increase in its authorized shares to support growth initiatives.

CareCloud正在徵集代理以批准增加其授權股份以支持增長計劃。

How many shares of Common Stock will CareCloud authorize?

CareCloud將授權多少普通股?

The proposal seeks to increase CareCloud's authorized shares from 35 million to 85 million.

該提議旨在將CareCloud的授權股份從3500萬增加到8500萬。

When will the Special Meeting for shareholders take place?

股東的特別會議將於何時舉行?

The Special Meeting will be held on January 27, 2025, for Common Stock shareholders to vote.

特別會議將於2025年1月27日舉行,供普通股股東投票。

How can shareholders vote during the proxy process?

股東如何在代理過程中投票?

Shareholders can vote via e-vote, mail, or by attending the Special Meeting in person.

股東可以通過電子投票、郵件或親自參加特別會議進行投票。

Where can I find more information about CareCloud's proxy statement?

在哪裏可以找到有關CareCloud代理聲明的更多信息?

Additional information is available on CareCloud's website and at the SEC's website, www.sec.gov.

更多信息可在CareCloud的網站和SEC的網站www.sec.gov上獲得。

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

免責聲明:這是由GlobeNewswire分發的新聞稿的人工智能生成摘要。用於總結這份稿件的模型可能會出錯。請在這裏查看完整發布。


$CCLD Insider Trading Activity

$CCLD 內部人士交易活動

$CCLD insiders have traded $CCLD stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

$CCLD 內部人士在過去6個月中已經1次在公開市場上交易了$CCLD股票。在這些交易中,有0次購買和1次售出。

Here's a breakdown of recent trading of $CCLD stock by insiders over the last 6 months:

以下是$CCLD股票近6個月內部人士的最新交易情況:

  • JOHN N DALY sold 10,000 shares.
  • JOHN N DALY 賣出了10,000股。

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

要跟蹤內部交易,請查看Quiver Quantitative的內部交易特斯拉-儀表。

$CCLD Hedge Fund Activity

$CCLD 對沖基金活動

We have seen 14 institutional investors add shares of $CCLD stock to their portfolio, and 13 decrease their positions in their most recent quarter.

我們已經看到14家機構投資者在他們最近的季度中增加了$CCLD股票的持股,而有13家減少了他們的倉位。

Here are some of the largest recent moves:

以下是一些最近最大的交易動態:

  • HERON BAY CAPITAL MANAGEMENT added 33,510 shares (+96.9%) to their portfolio in Q3 2024
  • BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 29,790 shares (-11.1%) from their portfolio in Q3 2024
  • MILLENNIUM MANAGEMENT LLC added 17,582 shares (+153.9%) to their portfolio in Q3 2024
  • XTX TOPCO LTD added 16,012 shares (+inf%) to their portfolio in Q3 2024
  • TWO SIGMA SECURITIES, LLC removed 13,863 shares (-100.0%) from their portfolio in Q3 2024
  • ACADIAN ASSET MANAGEMENT LLC removed 12,959 shares (-100.0%) from their portfolio in Q2 2024
  • ENGINEERS GATE MANAGER LP added 11,921 shares (+inf%) to their portfolio in Q3 2024
  • HERON BAY資產管理在2024年第三季度向其投資組合中增加了33,510股(+96.9%)
  • BRIDGEWAY資產管理, LLC 在2024年第三季度從其投資組合中減少了29,790股(-11.1%)
  • MILLENNIUM資產管理 LLC 在2024年第三季度向其投資組合中增加了17,582股(+153.9%)
  • XTX TOPCO LTD 在2024年第三季度向其投資組合中增加了16,012股(+inf%)
  • TWO SIGMA證券, LLC 在2024年第三季度從其投資組合中減少了13,863股(-100.0%)
  • ACADIAN資產管理 LLC 在2024年第二季度從其投資組合中減少了12,959股(-100.0%)
  • ENGINEERS GATE MANAGER LP 在2024年第三季度向其投資組合中增加了11,921股(+inf%

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

要追蹤對沖基金的股票組合,請查看Quiver Quantitative的機構持股儀表板。

Full Release

全面發佈




SOMERSET, N.J., Dec. 09, 2024 (GLOBE NEWSWIRE) --


CareCloud, Inc.

(the "Company" or "CareCloud") (Nasdaq: CCLD CCLDO, CCLDP), a leader in healthcare information technology solutions for medical practices and health systems nationwide, today announced the solicitation of proxies from its common stock (the "Common Stock") shareholders to approve an increase in its authorized shares. This increase is designed to support the Company's growth initiatives and corporate objectives.



新澤西州薩默塞特,2024年12月09日(環球新聞)--


CareCloud,Inc.

(「公司」或「CareCloud」)(納斯達克:CCLD CCLDO,CCLDP),作爲全國醫療實踐和健康系統的醫療信息科技解決方案的領導者,今天宣佈向其普通股(「普通股」)股東征求代理權,以批准增加其授權股份。這一增加旨在支持公司的增長計劃和企業目標。




Focus on Growth



專注於增長



Mahmud Haq, Founder and Executive Chairman of CareCloud's Board of Directors stated, "As CareCloud's largest common stockholder, Founder and Executive Chairman, I enthusiastically support this proposal. Our board and executive team collectively own more than 38% of the Common Stock and we firmly believe that increasing the number of authorized shares is essential to driving our revenue and profits – empowering us to deliver sustained, double-digit growth with a simultaneous, laser-like focus on profitability."


CareCloud董事會創始人兼執行主席Mahmud Haq表示:「作爲CareCloud最大的普通股東,創始人和執行主席,我熱情支持這一提案。我們的董事會和管理團隊共同持有超過38%的普通股,我們堅信增加授權股份的數量對提升我們的營業收入和利潤至關重要——使我們能夠實現持續的兩位數增長,同時專注於盈利能力。」



CareCloud, a leading developer and provider of healthcare information technology and AI solutions, has achieved a 23% compound annual growth rate ("CAGR") over the past decade through its focus on acquisitive and organic growth. During the first three quarters of 2024, the Company generated over $10 million in free cash flow and achieved a 50% year-over-year increase in adjusted EBITDA.


CareCloud是一家領先的醫療信息技術和人工智能解決方案開發和提供商,在過去十年中,通過專注於收購和有機增長,實現了23%的複合年增長率(「CAGR」)。在2024年的前三個季度,公司產生了超過1000萬的自由現金流,並實現了調整後 EBITDA 年同比增長50%。




The Proposal



提案



The board-supported proposal seeks to increase the Company's authorized shares of Common Stock from 35 million to 85 million. This increase is intended to provide the flexibility needed for strategic growth initiatives, including future acquisitions, and to enable the potential conversion of the Company's outstanding Series A Preferred Stock to Common Stock. Additionally, it supports investments in organic growth and other corporate priorities.


董事會支持的提案旨在將公司的授權普通股從3500萬增加到8500萬。此次增加旨在爲戰略增長計劃提供所需的靈活性,包括未來的收購,並使公司未償發行的A系列優先股能夠轉換爲普通股。此外,它支持對有機增長和其他企業優先事項的投資。



The Special Meeting of Common Stock Shareholders, which is scheduled for January 27, 2025, will enable holders of the Common Stock as of December 3, 2024 to vote on increasing the Company's authorized shares of Common Stock. Additional information regarding the Proxy is available on the Company's website and at www.sec.gov.


定於2025年1月27日召開的普通股股東特別會議將使截至2024年12月3日的普通股持有者能夠對增加公司的授權普通股進行投票。有關委託書的更多信息可在公司的官方網站和www.sec.gov上獲取。




How to Vote



如何投票



CareCloud encourages all shareholders to participate and ensure their voices are heard. Shareholders may vote through one of the following methods:


CareCloud鼓勵所有股東參與並確保他們的聲音被聽到。股東可以通過以下任一方式投票:





  • E-Vote


    : Shareholders may visit the website of the Company's transfer agent (



    ) and use the identified control number to vote on or before 11:59 pm Eastern Time on January 23, 2025. Alternatively, they may vote online through their investment broker by following their voting instructions.



  • Mail


    : Shareholders may mark, sign and date their proxy card, then detach it, and return it in the enclosed postage paid envelope. Proxies must be received by January 23, 2025, to be counted.



  • Attend the Special Meeting:


    Shareholders may attend and vote their shares at the Special Meeting on January 27, 2025.



  • 電子投票


    : 股東可以訪問公司的轉移代理人網站(



    ) 並使用識別的控制號碼在2025年1月23日東部時間晚上11:59之前投票。或者,他們也可以通過遵循其投票指示通過投資經紀人在線投票。



  • 郵寄


    股東可以在他們的委託票上標記、簽名並註明日期,然後將其撕下,並放入隨附的已付郵資的信封中寄回。代理投票必須在2025年1月23日之前收到,以便計算。



  • 參加特別會議:


    股東可以參加並在2025年1月27日的特別會議上投票他們的股份。



About


CareCloud



關於


CareCloud



CareCloud brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at



.


CareCloud將紀律性創新帶入醫療保健業務。我們一系列以科技爲驅動的解決方案幫助客戶提高財務和運營績效,簡化臨床工作流程,改善患者體驗。超過40,000名服務提供者依賴CareCloud幫助他們改善患者護理,同時降低行政負擔和運營成本。了解更多關於我們的產品和服務,包括營業收入管理(RCM),實踐管理(PM),電子健康記錄(EHR),商業智能,患者體驗管理(PXM)和互聯網醫療的信息,訪問



.



Follow CareCloud on


LinkedIn


,


Twitter


and


Facebook


.


關注CareCloud


LinkedIn


,


推特





Facebook


.




Important Additional Information and Where to Find It.

CareCloud filed with the SEC a Definitive Proxy Statement on Schedule 14A on December 5, 2024, with respect to its future solicitation of proxies for the Special Meeting of Common Stock Shareholders (including any and all adjournments, postponements, continuations, and reschedulings thereof, the "Special Meeting"). The information contained in this press release is merely a summary of certain relevant portions of the Definitive Proxy Statement and it is important that shareholders review the entirety of the filing.

SHAREHOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND ANY OTHER AMENDMENTS OR SUPPLEMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT CARECLOUD'S FILING

. Investors and security holders may obtain copies of these documents and other documents filed with the SEC by CareCloud free of charge through the website maintained by the SEC at

www.sec.gov

. The Notice of the Special Meeting of Common Stock Shareholders and our Definitive Proxy Statement for the Special Meeting, the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024 are available at

www.sec.gov

.



重要的額外信息及獲取渠道。

CareCloud於2024年12月5日向證券交易委員會提交了14A附表的最終委託書,涉及其未來針對普通股股東特別會議的委託徵集(包括所有的延期、推遲、繼續和重新安排,以下稱爲「特別會議」)。本新聞稿中包含的信息僅爲最終委託書某些相關部分的摘要,股東們務必審查所提交文件的全部內容。

股東被敦促仔細閱讀最終代理聲明及任何已向證券交易委員會(SEC)提交的修訂或補充文件,因爲這些文件包含或將包含有關CareCloud申報的重要信息

投資者和安防-半導體持有者可以通過證券交易委員會(SEC)維護的網站免費獲取這些文件及CareCloud向SEC提交的其他文件的副本

www.sec.gov

普通股股東特別會議的通知及我們特別會議的最終代理聲明、截至2023年12月31日的財政年度10-K表格年度報告以及截至2024年9月30日的季度報告10-Q表格可在以下網站獲取

www.sec.gov

.




Forward-Looking


Statements



前瞻性信息


報表



This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "shall," "should," "could", "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "seeks," "estimates," "predicts," "possible," "potential," "target," or "continue" or the negative of these terms or other comparable terminology.


這些前瞻性陳述既不是歷史事實,也不是對未來業績的保證。相反,它們僅是預測,具有不確定性,涉及重大的已知和未知的風險,不確定性和其他因素,這些因素可能會導致我們或行業實際結果,活動水平或表現與這些前瞻性陳述所表達的任何未來結果,活動水平或表現實質上不同。即使迄今爲止這些陳述與其他內容不同,我們也無持續更新股東有關未來代理或投票趨勢的義務。新的風險和不確定性時常出現,我們無法預測所有可能對前瞻性陳述產生影響的風險和不確定性,包括但不限於:公司管理增長的能力,遷移新收效較小的客戶和保留新的和現有的客戶,保持具有成本效益的全球運營,提高操作效率並降低運營成本,預測並適當地調整與醫療保健行業的變化和其他行業法規和趨勢相關的變化,保留關鍵人員的服務,開發新技術,升級並使遺留的和收購的技術適應與不斷髮展的行業標準的工作,與在競爭對手產品和服務方面具有競爭力的其他公司爭奪,以及在公司的SEC備案中參考和討論的其他重要風險和不確定性。



Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.


我們業務涉及的風險和不確定性很多,其中許多都超出了我們的控制能力,或是其中的一個或多個就能對我們的業績產生實質性影響,即便是前瞻性陳述最終被證明是正確的。在本新聞稿中,前瞻性陳述包括,但不僅限於,反映管理層對未來的財務表現和營運費用、預期增長、盈利能力和業務前景,疫情對我們的財務表現和業務活動的影響以及我們的收購的預期成果。這些前瞻性聲明既不是歷史事實,也不是未來業績的保證,而是預測未來,不確定的,涉及實質性已知和未知的風險、不確定性和其他因素,這些風險、不確定性和其他因素可能使我們(或我們所處的行業)的實際結果、活動數量或業績與這些前瞻性聲明所表達或暗示的未來結果、活動數量或業績有很大的不同。我們不必爲未來的委託或投票趨勢更新股東,即使它們與迄今爲止的情況有很大的不同。新的風險和不確定性時有出現,我們無法預測將會對前瞻性陳述產生影響的所有風險和不確定性,這些包括但不僅限於,公司管理增長、遷移新獲得的客戶和保留新老客戶、保持全球經營成本、提高運營效率並降低運營成本、預測和適應報銷和其他行業的規定和趨勢的變化、保留關鍵人員的服務、開發新的技術、升級和適應遺留和已獲得的技術符合不斷髮展的行業標準、與競爭對手公司的產品和服務進行競爭等重要的風險和不確定性,詳見公司向證券交易委員會提出的名爲「風險因素」的文件。



These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company's ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies' products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission.


這些前瞻性聲明既不是歷史事實,也不是對未來業績的保證。相反,它們僅僅是預測,具有不確定性,並涉及大量已知和未知的風險、不確定性以及其他因素,這些因素可能導致我們(或我們行業的)實際結果、活動水平或業績與這些前瞻性聲明所表達或暗示的任何未來結果、活動水平或業績有實質性差異。新的風險和不確定性不時出現,我們無法預測所有可能對前瞻性聲明產生影響的風險和不確定性,包括但不限於,與公司管理增長的能力、新獲取客戶的遷移和新舊客戶的保持、維持具有成本效益的全球運營、提高運營效率和降低運營成本、預測並適當地調整對報銷及其他行業法規和趨勢的變化、保留關鍵人員的服務、開發新技術、升級和調整遺留和獲得的技術以適應不斷髮展的行業標準、與其他公司具有競爭性的產品和服務競爭,以及在公司向證券交易委員會提交的文件中提到和討論的「風險因素」標題下的其他重要風險和不確定性。



The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.


本新聞稿中的聲明是在本新聞稿的日期上其發佈,即使稍後在公司的網站上或以其他方式提供或公開,公司也不承擔更新向前看陳述的義務,以反映發生的事件或存在的情況。



SOURCE CareCloud


消息來源CareCloud




Company


Contact:

Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.

nroth@carecloud.com



公司


聯繫方式:

Norman Roth
臨時首席財務官和企業控制器
CareCloud,Inc.

nroth@carecloud.com




Investor Contact:

Stephen Snyder
President
CareCloud, Inc.

ir@carecloud.com



投資者聯繫人:

Stephen Snyder
總裁
CareCloud,Inc.

ir@carecloud.com



声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論